We are live on ! Find out more
CP

Castleview Partners Portfolio holdings

AUM $228M
1-Year Est. Return 19.85%
This Fund
S&P 500
This Quarter Est. Return
+6.32%
1 Year Est. Return
+19.85%
3 Year Est. Return
+54.5%
5 Year Est. Return
10 Year Est. Return
AUM
$179M
AUM Growth
+$36.4M
Cap. Flow
+$27.1M
Cap. Flow %
15.1%
Top 10 Hldgs %
30.18%
Holding
955
New
94
Increased
315
Reduced
139
Closed
58

Sector Composition

Rank Sector Weight
1 Technology 8.46%
2 Consumer Discretionary 7.87%
3 Healthcare 6.43%
4 Financials 5.98%
5 Industrials 3.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEMR
126
DELISTED
Semrush
SEMR
$330K 0.18%
+24,870
New +$300K
CVX icon
127
Chevron
CVX
$383B
$328K 0.18%
2,078
+466
+29% +$70.3K
WDAY icon
128
Workday
WDAY
$41.7B
$325K 0.18%
1,193
+61
+5% +$17.4K
XLF icon
129
State Street Financial Select Sector SPDR ETF
XLF
$56.9B
$324K 0.18%
7,700
+7,622
+9,772% +$301K
BDTX icon
130
Black Diamond Therapeutics
BDTX
$95.1M
$324K 0.18%
+63,866
New +$258K
FAST icon
131
Fastenal
FAST
$54.4B
$315K 0.18%
8,178
+240
+3% +$8.48K
NVO
132
Novo Nordisk
NVO
$227B
$314K 0.18%
2,445
+30
+1% +$3.57K
AEO icon
133
American Eagle Outfitters
AEO
$2.91B
$308K 0.17%
+11,951
New +$265K
MCD icon
134
McDonald's
MCD
$193B
$306K 0.17%
1,087
+171
+19% +$49.7K
QTEC icon
135
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.35B
$304K 0.17%
1,594
-1,123
-41% -$207K
PSLV icon
136
Sprott Physical Silver Trust
PSLV
$11.7B
$301K 0.17%
36,286
+3,929
+12% +$30.8K
LLY icon
137
Eli Lilly
LLY
$1.09T
$296K 0.17%
380
EWTX icon
138
Edgewise Therapeutics
EWTX
$4.23B
$296K 0.17%
+16,204
New +$258K
META icon
139
Meta Platforms (Facebook)
META
$1.5T
$294K 0.16%
606
-35
-5% -$15.6K
IBM icon
140
IBM
IBM
$214B
$294K 0.16%
1,541
+239
+18% +$43.6K
NVDA icon
141
NVIDIA
NVDA
$4.64T
$292K 0.16%
3,230
-300
-8% -$21.7K
PPC icon
142
Pilgrim's Pride
PPC
$7.07B
$283K 0.16%
+8,239
New +$247K
AZPN
143
DELISTED
Aspen Technology Inc
AZPN
$278K 0.16%
+1,303
New +$257K
IDCC icon
144
InterDigital
IDCC
$6.79B
$274K 0.15%
+2,578
New +$272K
BTAI icon
145
BioXcel Therapeutics
BTAI
$25.1M
$274K 0.15%
+6,080
New +$290K
BA icon
146
Boeing
BA
$167B
$272K 0.15%
1,410
+19
+1% +$3.9K
PLMR icon
147
Palomar
PLMR
$3.83B
$272K 0.15%
+3,241
New +$222K
LMAT icon
148
LeMaitre Vascular
LMAT
$2.37B
$270K 0.15%
+4,066
New +$251K
ZYME icon
149
Zymeworks
ZYME
$1.61B
$269K 0.15%
+25,584
New +$284K
EFA icon
150
iShares MSCI EAFE ETF
EFA
$76.3B
$264K 0.15%
3,311
+1,194
+56% +$91.3K

Similar funds

Castleview Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Castleview Partners held 955 positions worth $179M, up 25% from $143M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Castleview Partners deployed $27.1M of net new capital in Q1 2024, opening 94 new positions and adding to 315 existing holdings. Its largest new stake was Regan Floating Rate MBS ETF: 877,935 shares worth $22.2M.

By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 8.5% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Acruence Active Hedge US Equity ETF, an estimated $24.4M trimmed.

  • Castleview Partners's largest Q1 2024 buy was Regan Floating Rate MBS ETF: 877,935 shares worth $22.2M.
  • Castleview Partners added most to Apple in Q1 2024, an estimated $2.31M increase.
  • Castleview Partners's biggest Q1 2024 reduction was Acruence Active Hedge US Equity ETF, cutting an estimated $24.4M.
  • Castleview Partners fully exited Columbia EM Core ex-China ETF in Q1 2024, selling an estimated $265K.
  • Castleview Partners's ten largest holdings make up 30% of its $179M portfolio in Q1 2024.
  • Castleview Partners opened 94 new positions and closed 58 in Q1 2024.
  • Castleview Partners's portfolio value rose 25% quarter-over-quarter to $179M.

Based on Castleview Partners's 13F filing for Q1 2024, filed 10 May 2024.